Lee Tien-Li
Transaction: 02/09/2026
SELL
Change
-203,851
Price
$13.48
Filing
02/11/2026
Type
SELL
Aardvark Therapeutics, Inc. Common Stock
AARD • Biotechnology
$5.38
▼ -0.35 (-6.11%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 62%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$117.53M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 10.61Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:59 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$5.38
Change-6.11%
Shares Out21.85M
Market Cap$117.53M
Enterprise Value$44.34M
52W Range3.35 - 17.94
Beta3.81
P/E-1.68
P/B1.57
P/FCF-1.69
EV/EBITDA-0.60
EV/FCF-0.64
Price$5.38
Change-6.11%
Shares Out21.85M
Market Cap$117.53M
Enterprise Value$44.34M
52W Range3.35 - 17.94
Beta3.81
P/E-1.68
P/B1.57
P/FCF-1.69
EV/EBITDA-0.60
EV/FCF-0.64
Earnings Yield-59.46%
FCF Yield-59.06%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio10.61
Quick Ratio10.61
Target$3.00
Target Upside-44.24%
Target Median$3.00
Target Range3.00 - 3.00
Volume130.86K
Avg Volume238.39K
EPS Surprise-0.12
Investment DNA
How strong this company looks for long-term investors
45
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
81/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 10.61Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 9 analyst votes · 2026-09-05
67/100
Neutral
Bullish
4
Hold
4
Bearish
1
Price Target
2026-08-14
Low
$3.00
Mean
$4.50
Median
$4.50
High
$6.00
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Jaiman Manasi
Transaction: 02/09/2026
SELL
Change
-70,549
Price
$13.48
Filing
02/11/2026
Type
SELL
Sun Nelson
Transaction: 02/09/2026
SELL
Change
-70,549
Price
$13.48
Filing
02/11/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Lee Tien-Li | SELL | -203,851 | $13.48 | 02/09/2026 | 02/11/2026 |
| Jaiman Manasi | SELL | -70,549 | $13.48 | 02/09/2026 | 02/11/2026 |
| Sun Nelson | SELL | -70,549 | $13.48 | 02/09/2026 | 02/11/2026 |
| Lee Tien-Li | BUY | +7,000 | $14.48 | 12/11/2025 | 12/12/2025 |
| Sun Nelson | BUY | +3,000 | $14.40 | 12/11/2025 | 12/12/2025 |
| Jones Bryan | BUY | +1,250 | $4.24 | 10/15/2025 | 10/16/2025 |
| Jones Bryan | SELL | -1,250 | $4.24 | 10/15/2025 | 10/16/2025 |
| Lee Tien-Li | SELL | -1,229 | $4.24 | 10/15/2025 | 10/16/2025 |
| Lee Tien-Li | BUY | +1,229 | $4.24 | 10/15/2025 | 10/16/2025 |
| Lee Tien-Li | BUY | +6,500 | $9.51 | 09/15/2025 | 09/16/2025 |
| Lee Tien-Li | BUY | +5,000 | $8.50 | 09/12/2025 | 09/12/2025 |
| Lee Tien-Li | BUY | +6,000 | $7.82 | 09/11/2025 | 09/12/2025 |
| Lee Tien-Li | BUY | +9,000 | $7.91 | 09/10/2025 | 09/12/2025 |
| Sun Nelson | BUY | +6,000 | $8.07 | 09/09/2025 | 09/10/2025 |
| Lee Tien-Li | SELL | -17,209 | $4.24 | 08/28/2025 | 08/29/2025 |
| Lee Tien-Li | BUY | +17,209 | $4.24 | 08/28/2025 | 08/29/2025 |
| Graf Susan E | BUY | +30,508 | $11.29 | 06/11/2025 | 06/13/2025 |
| Jones Bryan | BUY | +122,033 | $11.29 | 06/11/2025 | 06/13/2025 |
| Sun Nelson | BUY | +209,826 | $11.29 | 06/11/2025 | 06/13/2025 |
| Tong Victor Edward Jr | BUY | +61,017 | $11.29 | 06/11/2025 | 06/13/2025 |